PierpaoliCBasserPJ: Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med36: 893–906, 1996.
2.
ChenevertTLBrunbergJAPipeJG: Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology177: 401–5, 1990.
3.
BasserPJJonesDK: Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed15: 456–67, 2002-.
4.
ChanJHTsuiEYPehWC: Diffuse axonal injury: detection of changes in anisotropy of water diffusion by diffusion-weighted imaging. Neuroradiology45: 34–8, 2003.
5.
HuismanTASorensenAGHerganK: Diffusion-weighted imaging for the evaluation of diffuse axonal injury in closed head injury. J Comput Assist Tomogr27: 5–11, 2003.
6.
HuismanTASchwammLHSchaeferPW: Diffusion tensor imaging as potential biomarker of white matter injury in diffuse axonal injury. Am J Neuroradiol25: 370–6, 2004.
7.
HerganKSchaeferPWSorensenAG: Diffusion-weighted MRI in diffuse axonal injury of the brain. Eur Radiol12: 2536–41, 2002.
8.
BradleyPMenonD: Diffusion- and perfusion-weighter MR imaging in head injury. In GillardJHWaldmanABarkerP (Eds): Clinical MR Neuroimaging Diffusion, Perfusion and Spectroscopy. Cambridge, UK, Cambridge Universty Press2005: 626–641.
9.
SongSKSunSWRamsbottomMJ: Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage17: 1429–36, 2002.
10.
Le BihanD: Clinical perfusion and diffusion imaging. New York, Raven Press1993.
11.
Le BihanDManginJFPouponC: Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging13: 534–46, 2001.
SundgrenPCDongQGomez-HassanD: Diffusion tensor imaging of the brain: review of clinical applications. Neuroradiology46: 339–50, 2004.
14.
HolbournA: The mechanisms of brain injuries. Br Mell Bul3: 147–149, 1945.
15.
StrichS: Shearing of nerve fibers as a cause of damage due to head injury: A pathological study of twenty cases. Lancet2: 433–448, 1961.
16.
AdamsJHGrahamDIMurrayLS: Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann Neurol12: 557–63, 1982.
17.
WaxmanKSundineMJYoungRF: Is early prediction of outcome in severe head injury possible?Arch Surg126: 1237–42, 1991.
18.
LevinHSWilliamsDHEisenbergHM: Serial MRI and neurobehavioural findings after mild to moderate closed head injury. J Neurol Neurosurg Psychiatry55: 255–62, 1992.
19.
BiglerE: Neuroimaging adn atraumatic brain injury: Neur imaging II: Clinical applications. New York, Plenum Press, 262–278.
20.
SchaeferPWHuismanTASorensenAG: Diffusion-weighted MR imaging in closed head injury: high correlation with initial glasgow coma scale score and score on modified Rankin scale at discharge. Radiology233: 58–66, 2004.
ArfanakisKHaughtonVMCarewJD: Diffusion tensor MR imaging in diffuse axonal injury. AJNR Am J Neuroradiol23: 794–802, 2002.
23.
YangQTressBMBarberPA: Serial study of apparent diffusion coefficient and anisotropy in patients with acute stroke. Stroke30: 2382–90, 1999.
24.
ScheidRPreulCGruberO: Diffuse axonal injury associated with chronic traumatic brain injury: evidence from T2*-weighted gradient-echo imaging at 3 T. Am J Neuroradiol24: 1049–56, 2003.
25.
YanagawaYTsushimaYTokumaruA: A quantitative analysis of head injury using T2*-weighted gradient-echo imaging. J Trauma49: 272–7, 2000.
26.
LinDDFilippiCGSteeverAB: Detection of intracranial hemorrhage: comparison between gradient-echo images and b(0) images obtained from diffusion-weighted echo-planar sequences. Am J Neuroradiol22: 1275–81, 2001.
27.
TongKAAshwalSHolshouserBA: Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology227: 332–9, 2003.
28.
FriedmanSDBrooksWMJungRE: Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury. Am J Neuroradiol19: 1879–85, 1998.
29.
GarnettMRBlamireAMCorkillRG: Early proton magnetic resonance spectroscopy in normal-appearing brain correlates with outcome in patients following traumatic brain injury. Brain123: 2046–54, 2000.
30.
ChoeBYSuhTSChoiKH: Neuronal dysfunction in patients with closed head injury evaluated by in vivo 1H magnetic resonance spectroscopy. Invest Radiol30: 502–6, 1995.
BrooksWMStidleyCAPetropoulosH: Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. J Neurotrauma17: 629–40, 2000.
33.
SinsonGBagleyLJCecilKM: Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury. Am J Neuroradiol22: 143–51, 2001.
34.
CecilKMHillsECSandelME: Proton magnetic resonance spectroscopy for detection of axonal injury in the splenium of the corpus callosum of brain-injured patients. J Neurosurg88: 795–801, 1998.
35.
BrooksW: MR spectroscopy in traumatic brain injury. In GillardJHWaldmanABarkerP (Eds): Clinical MR Neuroimaging. Cambridge, UK, Cambridge University Press2005, 615.
36.
SchuhmannMUStillerDSkardellyM: Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study. J Neurotrauma20: 725–43, 2003.
37.
WildJMMacmillanCSWardlawJM: 1H spectroscopic imaging of acute head injury-evidence of diffuse axonal injury. Magma8: 109–15, 1999.
38.
GasparovicCArfaiNSmidN: Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury. J Neurotrauma18: 241–6, 2001.
39.
MacmillanCSWildJMWardlawJM: Traumatic brain injury and subarachnoid hemorrhage: in vivo occult pathology demonstrated by magnetic resonance spectroscopy may not be “ischaemic”. A primary study and review of the literature. Acta Neurochir (Wien)144: 853–62, 2002.
40.
DanielsenERChristensenPBArlien-SoborgP: Axonal recovery after severe traumatic brain injury demonstrated in vivo by 1H MR spectroscopy. Neuroradiology45: 722–4, 2003.
DavieCAHawkinsCPBarkerGJ: Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain117: 49–58, 1994.
43.
LienYHShapiroJIChanL: Effects of hypernatremia on organic brain osmoles. J Clin Invest85: 1427–35, 1990.
44.
BarzoPMarmarouAFatourosP: Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg87: 900–7, 1997.
45.
RossBDBlumlSCowanR: In vivo MR spectroscopy of human dementia. Neuroimaging Clin N Am8: 809–22, 1998.
46.
RicciRBarbarellaGMusiP: Localised proton MR spectroscopy of brain metabolism changes in vegetative patients. Neuroradiology39: 313–9, 1997.
47.
UzanMAlbayramSDashtiSG: Thalamic proton magnetic resonance spectroscopy in vegetative state induced by traumatic brain injury. J Neurol Neurosurg Psychiatry74: 33–8, 2003.
48.
HolshouserBAAshwalSLuhGY: Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children. Radiology202: 487–96, 1997.
49.
HaselerLJArcinueEDanielsenER: Evidence from proton magnetic resonance spectroscopy for a metabolic cascade of neuronal damage in shaken baby syndrome. Pediatrics99: 4–14, 1997.
50.
CondonBOluoch-OlunyaDHadleyD: Early 1H magnetic resonance spectroscopy of acute head injury: four cases. J Neurotrauma15: 563–71, 1998.
51.
AshwalSHolshouserBATomasiLG: 1H-magnetic resonance spectroscopy-determined cerebral lactate and poor neurological outcomes in children with central nervous system disease. Ann Neurol41: 470–81, 1997.
52.
BrennerTFreierMCHolshouserBA: Predicting neuropsychologic outcome after traumatic brain injury in children. Pediatr Neurol28: 104–14, 2003.
53.
AshwalSHolshouserBAShuSK: Predictive value of proton magnetic resonance spectroscopy in pediatric closed head injury. Pediatr Neurol23: 114–25, 2000.
54.
HolshouserBATongKAAshwalS: Proton MR spectroscopic imaging depicts diffuse axonal injury in children with traumatic brain injury. Am J Neuroradiol26: 1276–85, 2005.
55.
PriceSJBurnetNGDonovanT: Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?Clin Radiol58: 455–62, 2003.
56.
JohnsonPCHuntSJDrayerBP: Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiology170: 211–7, 1989.
57.
KellyPJDaumas-DuportCKispertDB: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg66: 865–74, 1987.
58.
LunsfordLDMartinezAJLatchawRE: Magnetic resonance imaging does not define tumor boundaries. Acta Radiol Suppl369: 154–6, 1986.
59.
WatanabeMTanakaRTakedaN: Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology34: 463–9, 1992.
60.
SchererJ: Structural development in gliomas. Am J Cancer34: 333–351, 1938.
61.
BurgerPCHeinzERShibataT: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg68: 698–704, 1988.
62.
MatsukadoYMaccartyCSKernohanJW: The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. J Neurosurg18: 636–44, 1961.
63.
WieshmannUCSymmsMRParkerGJ: Diffusion tensor imaging demonstrates deviation of fibres in normal appearing white matter adjacent to a brain tumour. J Neurol Neurosurg Psychiatry68: 501–3, 2000.
64.
LuSAhnDJohnsonG: Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology232: 221–8, 2004.
65.
SundgrenPFanXDongQ: Discrimination of brain tumor recurrence from radiation-induced injury using diffusion tensor imaging. ASNR238: 705–716, 2005.
66.
HirschJGBockMEssigM: Comparison of diffusion anisotropy measurements in combination with the flair-technique. Magn Reson Imaging17: 705–16, 1999.
67.
WieshmannUCClarkCASymmsMR: Reduced anisotropy of water diffusion in structural cerebral abnormalities demonstrated with diffusion tensor imaging. Magn Reson Imaging17: 1269–74, 1999.
68.
SinhaSBastinMEWhittleIR: Diffusion tensor MR imaging of high-grade cerebral gliomas. Am J Neuroradiol23: 520–7, 2002.
69.
SundgrenPFanXDongQ: Discrimination of brain tumor recurrence from radiation-induced injury using diffusion tensor imaging. ISMRM661: 149, 2005.
70.
WitwerBPMoftakharRHasanKM: Diffusion-tensor imaging of white matter tracts in patients with cerebral neoplasm. J Neurosurg97: 568–75, 2002.
71.
MoriSFrederiksenKvan ZijlPC: Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol51: 377–80, 2002.
72.
GuptaRKCloughesyTFSinhaU: Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol50: 215–26, 2000.
73.
CroteauDScarpaceLHearshenD: Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery49: 823–9, 2001.
74.
WeybrightPGomez-HassanDMalyP: Differentiation of tumor recurrence from treatment related changes using 2D-CSI MR spectroscopy. Am J Roentgenol2005.
75.
McDonaldWICompstonAEdanG: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol50: 121–7, 2001.
76.
KapellerPMcLeanMAGriffinCM: Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol248: 131–8, 2001.
77.
De StefanoNMatthewsPMAntelJP: Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol38: 901–9, 1995.
78.
ArnoldDLMatthewsPMFrancisGS: Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol31: 235–41, 1992.
79.
ArnoldDL: Magnetic resonance spectroscopy: imaging axonal damage in MS. J Neuroimmunol98: 2–6, 1999.
80.
De StefanoNNarayananSMatthewsPM: In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain122: 1933–9, 1999.
81.
TedeschiGBonavitaSMcFarlandHF: Proton MR spectroscopic imaging in multiple sclerosis. Neuroradiology44:37–42, 2002.
82.
TartagliaMCNarayananSDe StefanoN: Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol249: 1382–90, 2002.
83.
NarayanaPADoyleTJLaiD: Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol43: 56–71, 1998.
84.
SharmaRNarayanaPAWolinskyJS: Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler7: 221–6, 2001.
85.
SarchielliPPresciuttiOTarducciR: Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. J Neurol249: 902–10, 2002.
86.
IngleseMGeYFilippiM: Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage21: 1825–9, 2004.
87.
ChardDTGriffinCMMcLeanMA: Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain125: 2342–52, 2002.
88.
De StefanoNMatthewsPMFuL: Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain121: 1469–77, 1998.
89.
De StefanoNNarayananSFrancisGS: Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol58: 65–70, 2001.
90.
GonenOMoriartyDMLiBS: Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations. Radiology225: 261–8, 2002.
91.
HorsfieldMALaiMWebbSL: Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med36: 393–400, 1996.
92.
NusbaumAOLuDTangCY: Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. AJR Am J Roentgenol175: 821–5, 2000.
93.
DrooganAGClarkCAWerringDJ: Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging17: 653–61, 1999.
94.
WerringDJClarkCABarkerGJ: Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology52: 1626–32, 1999.
95.
BammerRAugustinMStrasser-FuchsS: Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med44: 583–91, 2000.
96.
ChristiansenPGideonPThomsenC: Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol Scand87: 195–9, 1993.
97.
FilippiMCercignaniMIngleseM: Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology56: 304–11, 2001.
98.
CercignaniMBozzaliMIannucciG: Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry70: 311–7, 2001.
99.
Castriota-ScanderbegAFasanoFHagbergG: Coefficient D(av) is more sensitive than fractional anisotropy in monitoring progression of irreversible tissue damage in focal nonactive multiple sclerosis lesions. AJNR Am J Neuroradiol24: 663–70, 2003.
100.
GuoACMacFallJRProvenzaleJM: Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology222: 729–36, 2002.
101.
GriffinCMChardDTCiccarelliO: Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult Scler7: 290–7, 2001.
102.
CaramiaFPantanoPDi LeggeS: A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging20: 383–8, 2002.
103.
BozzaliMCercignaniMSormaniMP: Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol23: 985–8, 2002.
104.
KiddDBarkhofFMcConnellR: Cortical lesions in multiple sclerosis. Brain122: 17–26, 1999.
105.
GeurtsJJBoLPouwelsPJ: Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Am J Neuroradiol26: 572–7, 2005.
106.
RovarisMBozzaliMIannucciG: Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch Neurol59: 1406–12, 2002.
107.
Castriota ScanderbegATomaiuoloFSabatiniU: Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. Am J Neuroradiol21: 862–8, 2000.
108.
NusbaumAOTangCYWeiT: Whole-brain diffusion MR histograms differ between MS subtypes. Neurology54: 1421–7, 2000.
109.
CercignaniMIngleseMPaganiE: Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. Am J Neuroradiol22: 952–8, 2001.
BrownM: Leukoariosis. In DooanGNorrvingBBamfordJ (Eds): Lacunar and other subcortical infarctions. Oxford, Oxford University Press1995.
112.
PantoniLGarciaJH: Pathogenesis of leukoaraiosis: a review. Stroke28: 652–9, 1997.
113.
JonesDKLythgoeDHorsfieldMA: Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. Stroke30: 393–7, 1999.
114.
PierpaoliCBarnettAPajevicS: Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage13: 1174–85, 2001.
115.
PfefferbaumASullivanEVHedehusM: In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholism. Alcohol Clin Exp Res24: 1214–21, 2000.
116.
PfefferbaumASullivanEV: Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage15: 708–18, 2002.
117.
PfefferbaumASullivanEV: Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imaging. Neuropsychopharmacology30: 423–32, 2005.
118.
ThurnherMCastilloMRiegerA: Diffusion tensor imaging (DTI) of the brain in HIV-positive patients. Am J Neuroradiol In press 2005.
119.
PomaraNCrandallDTChoiSJ: White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res106: 15–24, 2001.
120.
FilippiCGUlugAMRyanE: Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. Am J Neuroradiol22: 277–83, 2001.
121.
SteelRMBastinMEMcConnellS: Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatry Res106: 161–70, 2001.
122.
FoongJSymmsMRBarkerGJ: Investigating regional white matter in schizophrenia using diffusion tensor imaging. Neuroreport13: 333–6, 2002.
123.
HanyuHSakuraiHIwamotoT: Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J Neurol Sci156: 195–200, 1998.
124.
RoseSEChenFChalkJB: Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry69: 528–30, 2000.